| β-TrCP | Beta-transducin repeat containing E3 ubiquitin protein ligase |
| AAA | ATPases associated with diverse cellular activities |
| AFG3L2 | AFG3-like protein 2 |
| ALS | Amyotrophic lateral sclerosis |
| AMPK | AMP-activated protein kinase |
| BNIP3L | BCL2 interacting protein 3 like |
| BRD7 | Bromodomain-containing protein 7 |
| CLPP | Clp protease proteolytic subunit |
| CUL1 | Cullin 1 |
| CUL3 | Cullin 3 |
| ERK | Extracellular signal-regulated kinase |
| FDA | Food and Drug Administration, USA |
| HRD1 | HMG-CoA reductase degradation 1 homolog |
| IDH2 | Isocitrate dehydrogenase 2 |
| IKKβ | Inhibitor of nuclear factor kappa-B kinase subunit beta |
| JNK | c-Jun N-terminal kinase |
| KEAP1 | Kelch-like ECH-associated protein 1 |
| MAPK | Mitogen-activated protein kinase |
| NADPH | Nicotinamide adenine dinucleotide phosphate, reduced form |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NRF2 | Nuclear factor erythroid 2-related factor 2 |
| PGC-1α | Peroxisome proliferator-activated receptor gamma coactivator-1 alpha |
| PI3K | Phosphoinositide 3-kinase |
| PINK1 | PTEN-induced kinase 1 |
| RBX1 | Ring box 1 |
| SKP1 | S-phase kinase-associated protein 1 |
| sMAF | Small musculoaponeurotic fibrosarcoma |
| SPG7 | Spastic paraplegia 7 |
| TCA | Tricarboxylic acid |
| VEGF-B | Vascular endothelial growth factor B |